Tirzepatide recalls
The FDA has published 16 recalls involving Tirzepatide since 2023. The latest was reported on 21 Oct 2026. Most were for sterility. Carolina Infusion has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls16since 2023
Last 12 months8reported
Class I16% of total
Ongoing16latest 21 Oct 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 6%Class II 15 94%Class III 0 0%
Why tirzepatide is recalled
Companies
By year
Ongoing tirzepatide recalls
16 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Tirzepatide/Niacinamide vial (40 MG per Vial) Inj 20mg/2mg/mL recalled | Houston Rx | Sterility | Nationwide |
| Drug | CLASS II | Tirzepatide 26 MG/ML Injectable recalled by Carolina Infusion | Carolina Infusion | Sterility | Nationwide |
| Drug | CLASS II | Tirzepatide/cyanocobalamin 76/2 MG/ML Injectable recalled | Carolina Infusion | Sterility | Nationwide |
| Drug | CLASS II | Tirzepatide/cyanocobalamin 64/2 MG/ML Injectable recalled | Carolina Infusion | Sterility | Nationwide |
| Drug | CLASS II | Tirzepatide/cyanocobalamin 85/2 MG/ML Injectable recalled | Carolina Infusion | Sterility | Nationwide |
| Drug | CLASS II | Tirzepatide Injection, 18mg/mL Sterile Multi-Dose Vial recalled | Apothecary Pharma | Sterility | Nationwide |
All tirzepatide recalls, newest first
16 totalShould you stop taking Tirzepatide?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.